GlassScriptPhysician profile
Chad Michael Feldman
NPI 1134333289
$1,287.32
in general payments reported to CMS, 2019-2025
18 companies · $54.67 in 2025
The $54.67 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,038 · 2021: $11.52 · 2022: $114 · 2023: $46.88 · 2024: $22.44 · 2025: $54.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $123.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $359.17 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $186.44 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $122.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $97.33 | 2019 | |
| Amarin Pharma, INC. | $80.67 | 2019 | |
| Pfizer INC. | $78.94 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $78.10 | 2019 | |
| Amgen INC. | $45.66 | 2019 | |
| Astellas Pharma US INC | $40.27 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $38.43 | 2019 | |
| Abbott Laboratories | $27.58 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $26.21 | 2019 | |
| Vifor Pharma, INC. | $22.92 | 2019 | |
| Novo Nordisk INC | $22.66 | 2022 | |
| Lantheus Medical Imaging, INC. | $22.44 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $15.09 | 2019 | |
| Boston Scientific Corporation | $11.71 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Feldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.